Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
1. 系统已在2026-08-24 13:15:13对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.4c01305
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c01305
其他信息:
出版社: American Chemical Society (ACS)
作者: Xiaozhang Zheng; Nan Ji; Veronica Campbell; Anthony Slavin; Xiao Zhu; Dapeng Chen; Haojing Rong; Brad Enerson; Michele Mayo; Kirti Sharma; Chris M. Browne; Christine R. Klaus; Haoran Li; Ginny Massa; Alice A. McDonald; Yatao Shi; Mike Sintchak; Stephanie Skouras; Dirk M. Walther; Karen Yuan; Yi Zhang; Joe Kelleher; Guang Liu; Xinbo Luo; Nello Mainolfi; Matthew M. Weiss
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c01305
